Skip to content
Screener

Sabra Healthcare SBRA Q2 2026 earnings

Reported August 3, 2026 · After market close

Revenue$235.9MBeat by $16.5M
EPS-$0.10Miss by $0.27
Revenue estimate$219.4M
EPS estimate$0.17
“Sabra delivered another solid quarter. Our same-store managed portfolio cash NOI growth continued to be healthy. Both our consolidated and unconsolidated managed portfolio came in with strong margin growth as well as increased occupancy. Our triple-net skilled nursing portfolio rent coverage increased yet again. The triple-net senior housing portfolio saw drops in occupancy and coverage simply due to the conversion of a high-performing triple-net asset to the managed portfolio. Otherwise, it would have been flat. In aggregate, our top ten tenants again showed increased coverage. Sabra has now closed on approximately $600 million in investments this year, with another $100 million in the process of closing. Even with the addition of a few value-add opportunities, we are still getting transactions done at attractive yields. Our investment pipeline remains robust and consists almost entirely of senior housing opportunities. Our leverage, which was noted to be down to 4.8x in our recent business update, was 4.6x as of June 30. We look forward to a strong finish for the year.”
Rick Matros

Next report

Nov 2, 2026 (Today)
Revenue estimate$236.6M
EPS estimate$0.16

Financials

Q2 2026

Income statement

See full
Revenue$235.9M+24.7%
Net income-$25.2M-138%
EPS (diluted)-$0.10-137%

Balance sheet

See full
Cash & equivalents$231.6M+143%
Total debt$7.2M-8.4%
Total equity$2.8B+1.4%
Total assets$5.5B+3.5%

Cash flow

See full
Operating cash flow$85.8M+6.0%

Valuation & ratios

Valuation

as of 10/30/26
See full
Market cap$5.01B+19.6%
Enterprise value$4.79B+19.7%
P/E76.6×+52.6×
P/S5.8×+0.2×

Profitability

See full
Net margin7.6%-17.3pp

Returns & leverage

See full
Return on equity2.4%-4.3pp
Debt / equity0×0.0×

FAQ

When did Sabra Healthcare report Q2 2026 earnings?
Sabra Healthcare (SBRA) reported Q2 2026 earnings on August 3, 2026 after market close.
What were Sabra Healthcare's Q2 2026 revenue and EPS?
Sabra Healthcare reported revenue of $235.9M and eps of $-0.10 for Q2 2026.
Did Sabra Healthcare beat estimates in Q2 2026?
Revenue beat the consensus estimate of $219.4M by $16.5M. EPS missed the consensus estimate of $0.17 by $0.27.
How did Sabra Healthcare's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 24.7% from $189.2M a year earlier.
Where can I find Sabra Healthcare's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001492298-26-000027) and the 10-Q periodic report (0001492298-26-000028) directly on SEC EDGAR. The filing index links above go to sec.gov.